09.12.2012 Views

Second edition

Second edition

Second edition

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

20.qxd 3/10/08 9:58 AM Page 626<br />

626 Idiopathic psychotic, mood, and anxiety disorders<br />

some may believe that all are dead, that death has finally<br />

achieved complete dominion over the world. Auditory hallucinations<br />

may also occur and generally reflect the patients’<br />

delusions. Voices may accuse them of crimes or sins, or<br />

announce that their well-deserved punishment is at hand.<br />

Visual hallucinations occasionally occur, and patients may<br />

see corpses or accusatory spirits. In some cases patients may<br />

develop stuporous catatonia (Starkstein et al. 1996).<br />

Other symptoms seen during a minority of depressive<br />

episodes include anxiety attacks (Van Valkenburg et al.<br />

1984) and what have been called ‘anger attacks’, in which<br />

generally hostile and irritable patients occasionally experience<br />

episodes of violence and autonomic arousal (Fava et al.<br />

1993). Obsessions and compulsions may also appear: a particularly<br />

common obsession is the ‘horrific temptation’ to<br />

use a knife or gun to kill a loved one, and a consequent overwhelming<br />

necessity to rid the house of all potential weapons<br />

and to avoid any contact with them outside the house.<br />

Course<br />

Major depressive disorder is a relapsing and remitting illness<br />

(Thase 1990), characterized in most patients by the<br />

recurrence of depressive episodes throughout their lives, in<br />

between which they return to a more or less normal mood.<br />

As noted earlier, in about 50 percent of cases, depressive<br />

episodes will undergo a spontaneous remission within<br />

6–12 months. The duration of the interval between successive<br />

episodes ranges widely, from as little as 1 year up to<br />

decades, with an overall average of about 5 years. In general,<br />

however, with repeated episodes the interval between<br />

episodes tends to shorten, and the episodes themselves<br />

tend to lengthen, such that, over a very long period of time,<br />

successive episodes may eventually ‘merge’ to create a<br />

chronic, non-remitting condition.<br />

Recently, much attention has been focused on patients<br />

whose depressive episodes seem entrained to the changing<br />

seasons. In patients with this seasonal pattern of illness,<br />

depressive episodes appear to occur far more commonly in<br />

the fall or winter than in the spring or summer.<br />

Etiology<br />

Hereditary factors appear to play a role: the prevalence of<br />

major depression is higher in the relatives of patients than<br />

of control subjects, and the monozygotic concordance rate<br />

is significantly higher than the dizygotic one (McGuffin<br />

et al. 1996). To date, however, genetic studies have not<br />

identified genes or loci that may be confidently associated<br />

with this illness, indicating in all likelihood that, from a<br />

genetic point of view, this is a complex disorder, involving<br />

multiple genes and multiple modes of inheritance.<br />

Hereditary factors, although clearly important, do<br />

not appear to provide a complete account, and environmental<br />

factors also seem to play a role. Among the various<br />

environmental events proposed, it appears that early childhood<br />

loss may be the most important. Events may also<br />

serve as precipitants for episodes in adult life; however, as<br />

noted earlier, the importance of precipitants fades with<br />

successive episodes to the point where, over long periods of<br />

time, episodes become, as it were, autonomous.<br />

There is abundant evidence for endocrinologic disturbances<br />

in depression, all of which point to disturbances in<br />

the hypothalamus. Within the hypothalamus, for example,<br />

the level of messenger RNA for CRH in the paraventricular<br />

nucleus is elevated (Raadsheer et al. 1995), as is the cerebrospinal<br />

fluid (CSF) level of CRH (Nemeroff et al. 1984);<br />

consistent with this, the low-dose DST test is generally positive<br />

(Carroll et al. 1968, 1976). The thyroid axis also shows<br />

disturbances: the CSF level of TRH is elevated (Banki et al.<br />

1988), and, consistent with this, the response of TSH to<br />

exogenous TRH is blunted (Prange et al. 1972).<br />

Abnormalities in brainstem structures responsible for<br />

REM sleep are suggested by the fact that REM sleep latency<br />

is reduced in depression (Hauri et al. 1974; Rush et al.<br />

1986), and by the response to cholinergic agents.<br />

Normally, REM sleep may be induced by cholinergic stimulation;<br />

however, in patients with major depressive disorder<br />

the latency to REM sleep with such cholinergic agents<br />

as arecoline (Gillin et al. 1991) and donepezil (Perlis et al.<br />

2002) is shorter than in control subjects.<br />

The undoubted success of antidepressant medications has<br />

focused attention on biogenic amines. Given that all antidepressants<br />

have effects on either noradrenergic or serotoninergic<br />

functioning, it appears reasonable to assume that there<br />

is a complementary disturbance in these amines in patients<br />

with major depressive disorder. Despite enormous research<br />

efforts, however, it has been difficult to isolate definite abnormalities<br />

here. One notable exception involves the effects of<br />

tryptophan depletion. Tryptophan is the dietary precursor of<br />

serotonin and, in patients with an antidepressant-induced<br />

remission of depression, tryptophan depletion is promptly<br />

followed by a relapse of depressive symptoms (Aberg-Wistedt<br />

et al. 1998; Delgado et al. 1990; Smith et al. 1997).<br />

Relatively speaking, neuropathologic studies are in their<br />

infancy in this disorder. Some studies have suggested<br />

changes in the dorsolateral prefrontal cortex; however, in<br />

my opinion the endocrinologic and sleep abnormalities<br />

point rather to the diencephalon or brainstem as the most<br />

likely sites for any changes. In this regard, several, albeit<br />

preliminary, findings have been reported, including the<br />

following; an increased number of neurons in the<br />

mediodorsal nucleus of the thalamus (Young et al. 2004);<br />

an overall decreased number of neurons in the paraventricular<br />

nucleus of the hypothalamus (Manaye et al.<br />

2005) with a relative increase in the number of CRH-containing<br />

neurons in the same nucleus (Bao et al. 2005).<br />

Integrating all of the foregoing findings into a coherent<br />

theory is problematic and involves some speculation. With<br />

this caveat in mind, however, it may be reasonable to propose<br />

that major depressive disorder represents an interaction<br />

between certain environmental events and an inherited

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!